Alimera Sciences reported $70K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Abbvie ABBV:US $ 18M 0M
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Alimera Sciences ALIM:US $ 0.07M 0M
Applied Genetic Technologies AGTC:US $ 0.05M 0.01M
Bayer BAYN:GR € 2515M 0M
Insmed INSM:US $ 1.19M 6K
Novartis NOVN:VX SF 901M 0M
Ophthotech OPHT:US $ 0.12M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M